重症流感ICU患者侵袭性曲霉病:回顾性队列研究
该回顾性多中心队列研究纳入比利时和荷兰7个ICU在2009年1月1日至2016年6月30日7个流感季节收治的成人重症流感患者(>18岁、ICU停留>24小时、急性呼吸衰竭、影像学肺浸润、气道PCR确诊流感)。流感队列432例中83例(19%)诊断侵袭性肺曲霉病,中位诊断时间为入ICU后3天。免疫功能受损流感患者发生率高达32%(38/117),非免疫功能受损流感病例组为14%(45/315),而流感PCR阴性的非免疫功能受损重症社区获得性肺炎对照组仅5%(16/315)。流感队列中合并曲霉病者90天死亡率51%,无曲霉病者28%(p=0.0001)。校正后流感与侵袭性肺曲霉病独立相关(校正OR 5.19;95%CI 2.63-10.26;p<0.0001),其他相关因素包括较高APACHE II评分、男性和使用糖皮质激素。
要点
- 重症流感ICU患者中侵袭性肺曲霉病发生率为19%(83/432),中位诊断时间为入ICU后3天。
- 免疫功能受损的流感患者曲霉病发生率32%(38/117),非免疫功能受损流感患者为14%(45/315)。
- 非免疫功能受损流感患者曲霉病发生率14%(45/315)显著高于流感PCR阴性重症社区获得性肺炎对照组的5%(16/315)。
- 流感队列中合并侵袭性肺曲霉病者90天死亡率为51%,无曲霉病者为28%(p=0.0001)。
- 流感与侵袭性肺曲霉病独立相关(校正OR 5.19;95%CI 2.63-10.26;p<0.0001),其他相关因素为较高APACHE II评分、男性和使用糖皮质激素。
适用人群与场景
- 成人(>18岁)重症流感患者,因急性呼吸衰竭入住ICU超过24小时,影像学有肺浸润,气道PCR确诊流感。
- 研究纳入比利时和荷兰7个ICU在2009年1月1日至2016年6月30日7个流感季节收治的患者。
- 对照为非免疫功能受损的重症社区获得性肺炎患者,气道流感PCR阴性。
诊断标准与关键阈值
- 侵袭性肺曲霉病诊断依据原文未详细列出具体标准。
- 免疫功能受损定义采用EORTC/MSG宿主因素标准。
研究设计与关键结果
- 研究类型为回顾性多中心队列研究,纳入7个ICU、7个流感季节的成人重症流感患者。
- 流感队列432例中83例(19%)诊断侵袭性肺曲霉病,中位诊断时间为入ICU后3天,流感A和B发生率相似。
- 免疫功能受损流感患者曲霉病发生率为32%(38/117),非免疫功能受损流感病例组为14%(45/315)。
- 对照组315例中仅16例(5%)发生侵袭性肺曲霉病。
- 流感队列中合并曲霉病者90天死亡率为51%,无曲霉病者为28%(p=0.0001)。
- 校正后流感与侵袭性肺曲霉病独立相关(校正OR 5.19;95%CI 2.63-10.26;p<0.0001),其他相关因素包括较高APACHE II评分、男性和使用糖皮质激素。
证据类型、等级与局限
- 证据类型为回顾性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来研究应评估更快速的诊断或抗真菌预防能否改善流感相关曲霉病的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Invasive pulmonary aspergillosis typically occurs in an immunocompromised host. For almost a century, influenza has been known to set up for bacterial superinfections, but recently patients with severe influenza were also reported to develop invasive pulmonary aspergillosis. We aimed to measure the incidence of invasive pulmonary aspergillosis over several seasons in patients with influenza pneumonia in the intensive care unit (ICU) and to assess whether influenza was an independent risk factor for invasive pulmonary aspergillosis.
METHODS: We did a retrospective multicentre cohort study. Data were collected from adult patients with severe influenza admitted to seven ICUs across Belgium and The Netherlands during seven influenza seasons. Patients were older than 18 years, were admitted to the ICU for more than 24 h with acute respiratory failure, had pulmonary infiltrates on imaging, and a confirmed influenza infection based on a positive airway PCR test (influenza cohort). We used logistic regression analyses to determine if influenza was independently associated with invasive pulmonary aspergillosis in non-immunocompromised (ie, no European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [EORTC/MSG] host factor) influenza-positive patients (influenza case group) compared with non-immunocompromised patients with severe community-acquired pneumonia who had a negative airway influenza PCR test (control group).
FINDINGS: Data were collected from patients admitted to the ICU between Jan 1, 2009, and June 30, 2016. Invasive pulmonary aspergillosis was diagnosed in 83 (19%) of 432 patients admitted with influenza (influenza cohort), a median of 3 days after admission to the ICU. The incidence was similar for influenza A and B. For patients with influenza who were immunocompromised, incidence of invasive pulmonary aspergillosis was as high as 32% (38 of 117 patients), whereas in the non-immunocompromised influenza case group, incidence was 14% (45 of 315 patients). Conversely, only 16 (5%) of 315 patients in the control group developed invasive pulmonary aspergillosis. The 90-day mortality was 51% in patients in the influenza cohort with invasive pulmonary aspergillosis and 28% in the influenza cohort without invasive pulmonary aspergillosis (p=0·0001). In this study, influenza was found to be independently associated with invasive pulmonary aspergillosis (adjusted odds ratio 5·19; 95% CI 2·63-10·26; p<0·0001), along with a higher APACHE II score, male sex, and use of corticosteroids.
INTERPRETATION: Influenza was identified as an independent risk factor for invasive pulmonary aspergillosis and is associated with high mortality. Future studies should assess whether a faster diagnosis or antifungal prophylaxis could improve the outcome of influenza-associated aspergillosis.
参考来源
- Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018. PMID: 30076119. doi:10.1016/S2213-2600(18)30274-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。